Christina Henson to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Christina Henson has written about Antineoplastic Agents, Immunological.
Connection Strength
0.058
-
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial. Lancet Oncol. 2024 Dec; 25(12):1576-1588.
Score: 0.058